GL1X · GenesisL1 explorer

MolNFT v1 · #166695 · protein

Cryo-EM structure of wild-type bovine multidrug resistance protein 1 (MRP1) under active turnover conditions

6UY0 · Multidrug resistance-associated protein 1: “Cryo-EM structure of wild-type bovine multidrug resistance protein 1 (MRP1) under active turnover conditions”. Electron microscopy, 4 ligands (CLR, ATP, ADP), 20 pockets (best druggability…

PDB
6UY0
Type
protein
Length
1,210 residues
Chains
1
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Multidrug resistance-associated protein 1
EC
7.6.2.2, 7.6.2.3
UniProt
Q8HXQ5
Ligands
CLR, ATP, ADP, MG
Pockets
20 · best druggability 0.89

Structure

electron microscopy · 1 distinct chain · 61% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMultidrug resistance-associated protein 1 (EC 7.6.2.2, 7.6.2.3)protein121061% helix, 10% strandQ8HXQ5

Ligands and binding sites

  • CLR · Cholesterol · ligand · 3 copies · chains A
  • ATP · Adenosine-5'-triphosphate · ligand · chains A
  • ADP · Adenosine-5'-diphosphate · ligand · chains A
  • MG · Magnesium ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110850.890.90117empty
29160.880.90112ADP, MG
34330.730.8350empty
44400.680.7954CLR
52060.620.8221empty

Compared structures

  • 6UY0 · Cryo-EM structure of wild-type bovine multidrug resistance protein 1 (MRP1) under active… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8HXQ5 · AlphaFold monomer V2.0 prediction for multidrug resistance-associated protein 1 (Q8HXQ5) · a predicted model of the same protein · chain A against A, TM-score 0.87

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.